GMG

Clinical trials for GMG explained in plain language.

Never miss a new study

Get alerted when new GMG trials appear

Sign up with your email to follow new studies for GMG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 3 Completed 1

New dosing strategy aims to keep myasthenia gravis symptoms under control

Disease control Completed

This study tested two ways of giving the drug efgartigimod to people with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. One group received the drug on a regular, continuous schedule, while the other got it in cycles. The goal was to see which appro…

Matched conditions: GMG

Phase: PHASE3 • Sponsor: argenx • Aim: Disease control

Last updated May 15, 2026 11:53 UTC

GMG

Get alerted when new GMG trials appear

New dosing strategy aims to keep myasthenia gravis symptoms under control